HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Posterior interbody grafting and instrumentation for spondylodiscitis.

AbstractPURPOSE:
To report outcomes of 7 patients with bacterial spondylodiscitis treated through a posterior approach.
METHODS:
Five men and 2 women aged 40 to 80 years underwent one-stage posterior interbody debridement and instrumentation for single-segment bacterial spondylodiscitis of lumbar (n=5) or thoracic (n=2) vertebrae. The Oswestry Disability Score, the Frankel classification, the Cobb angle, and the visual analogue scale (VAS) for pain as well as bone union on radiographs were assessed.
RESULTS:
Patients were followed up for 19 to 36 months. None had relapses or complications. Postoperatively, 5 patients had no pain or used analgesics only occasionally; their VAS scores varied from 0 to 20. The remaining 2 patients had residual symptoms and received regular peripheral pain medication and opiates; their VAS scores ranged from 30 to 50. The mean Oswestry Disability Score improved to 21 (range, 12-38). The mean Cobb angle improved from 13.1 to 11.1 degrees. The segments were probably fused in 5 patients and questionable in 2.
CONCLUSION:
Posterior debridement and instrumentation was adequate for single-segment spondylodiscitis and achieved good outcomes.
AuthorsStefan Endres, Axel Wilke
JournalJournal of orthopaedic surgery (Hong Kong) (J Orthop Surg (Hong Kong)) Vol. 20 Issue 1 Pg. 1-6 (Apr 2012) ISSN: 2309-4990 [Electronic] England
PMID22535802 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Discitis (microbiology, surgery)
  • Female
  • Humans
  • Ilium (transplantation)
  • Lumbar Vertebrae
  • Male
  • Middle Aged
  • Spinal Fusion (instrumentation, methods)
  • Staphylococcal Infections (surgery)
  • Thoracic Vertebrae

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: